Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):13990-5. doi: 10.1073/pnas.222433299. Epub 2002 Oct 9.

Abstract

Despite extensive deposition of putatively neurotoxic amyloid-beta (Abeta) protein in the brain, it has not been possible to demonstrate an association of Abeta deposits with neuronal loss in Alzheimer's disease (AD), and neuronal loss is minimal in transgenic mouse models of AD. Using triple immunostaining confocal microscopy and analyzing the images with the cross-correlation density map method from statistical physics, we directly compared Abeta deposition, Abeta morphology, and neuronal architecture. We found dramatic, focal neuronal toxicity associated primarily with thioflavin S-positive fibrillar Abeta deposits in both AD and PSAPP mice. These results, along with computer simulations, suggest that Abeta develops neurotoxic properties in vivo when it adopts a fibrillar beta-pleated sheet conformation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Benzothiazoles
  • Disease Models, Animal
  • Female
  • Humans
  • Male
  • Membrane Proteins / genetics
  • Mice
  • Mice, Transgenic
  • Neurotoxins / metabolism*
  • Plaque, Amyloid
  • Presenilin-1
  • Thiazoles / metabolism*

Substances

  • Amyloid beta-Peptides
  • Benzothiazoles
  • Membrane Proteins
  • Neurotoxins
  • PSEN1 protein, human
  • Presenilin-1
  • Thiazoles
  • thioflavin T